Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversification.
Détails
Télécharger: 35263577.pdf (3321.93 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_114B7364DECA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Critical role of WASp in germinal center tolerance through regulation of B cell apoptosis and diversification.
Périodique
Cell reports
ISSN
2211-1247 (Electronic)
Statut éditorial
Publié
Date de publication
08/03/2022
Peer-reviewed
Oui
Volume
38
Numéro
10
Pages
110474
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
A main feature of Wiskott-Aldrich syndrome (WAS) is increased susceptibility to autoimmunity. A key contribution of B cells to development of these complications has been demonstrated through studies of samples from affected individuals and mouse models of the disease, but the role of the WAS protein (WASp) in controlling peripheral tolerance has not been specifically explored. Here we show that B cell responses remain T cell dependent in constitutive WASp-deficient mice, whereas selective WASp deletion in germinal center B cells (GCBs) is sufficient to induce broad development of self-reactive antibodies and kidney pathology, pointing to loss of germinal center tolerance as a primary cause leading to autoimmunity. Mechanistically, we show that WASp is upregulated in GCBs and regulates apoptosis and plasma cell differentiation in the germinal center and that the somatic hypermutation-derived diversification is the basis of autoantibody development.
Mots-clé
Animals, Apoptosis, Autoantibodies, Germinal Center/pathology, Mice, Mice, Knockout, Wasps, Wiskott-Aldrich Syndrome/pathology, Wiskott-Aldrich syndrome, autoimmunity, germinal center B cells
Pubmed
Web of science
Open Access
Oui
Financement(s)
Fonds national suisse / Projets / 310030-179251
Création de la notice
10/03/2022 16:36
Dernière modification de la notice
21/11/2022 8:20